Virpax Pharmaceuticals Inc (VRPX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Operating Expenses | 3,395 | 1,924 | 3,458 | 3,303 | 4,684 |
| Operating Income | -3,395 | -1,924 | -3,458 | -3,303 | -4,684 |
| Interest Expense | 0 | 93 | 11 | 0 | 0 |
| Other Income | 5 | 11 | 19 | 82 | 122 |
| Pre-tax Income | -3,390 | -2,007 | -3,450 | -3,220 | -4,562 |
| Net Income Continuous | -3,390 | -2,007 | -3,450 | -3,220 | -4,562 |
| Net Income | $-3,390 | $-2,007 | $-3,450 | $-3,220 | $-4,562 |
| EPS Basic Total Ops | 52.25 | -10.75 | -43.75 | -68.75 | -97.25 |
| EPS Basic Continuous Ops | 52.23 | -10.77 | -43.63 | -68.74 | -97.37 |
| EPS Diluted Total Ops | 52.25 | -10.75 | -43.75 | -68.75 | -97.25 |
| EPS Diluted Continuous Ops | 52.23 | -10.77 | -43.63 | -68.74 | -97.37 |
| EPS Diluted Before Non-Recurring Items | N/A | -10.75 | -43.75 | -68.75 | N/A |
| EBITDA(a) | $-3,395 | $-1,924 | $-3,458 | $-3,303 | $-4,684 |